1-10 of 10
Taehyung Simon Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Allogeneic Hematopoietic Stem Cell Transplant (HCT) in First Remission Beneficial to Acute Myeloid Leukemia (AML) Patients with Isocitrate Dehydrogenase(IDH) Mutations?

Ayman Sayyed, Taehyung Simon Kim, Silvia Park, Jae-Sook Ahn, Aly Karsan, Marie-France Gagnon, Julie Bergeron, Hyeoung-Joon Kim, Heeje Kim, David Sanford, Andre C. Schuh, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4960.
https://doi.org/10.1182/blood-2023-191113
Published: 2023
Journal Articles

Acute Myeloid Leukemia (AML) Patients with Myelodysplasia (MDS) Related-Gene Mutations in First Complete Remission (CR1) Found to Have Benefit from Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Ayman Sayyed, Taehyung Simon Kim, Silvia Park, Jae-Sook Ahn, Aly Karsan, Marie-France Gagnon, Julie Bergeron, Hee-Je Kim, Hyeoung-Joon Kim, David Sanford, Andre C. Schuh, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4954.
https://doi.org/10.1182/blood-2023-191011
Published: 2023
Journal Articles

The Presence of Somatic Mutations on Specific Pathways Such As Chromatin Modifier, Spliceosome, and Myeloid Transcription Factor at Diagnosis Was Found to Have Benefit from Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in 1,228 Patients with Acute Myeloid Leukemia in First Complete Remission (CR1)

Ayman Sayyed, Taehyung Simon Kim, Silvia Park, Jae-Sook Ahn, Aly Karsan, Marie-France Gagnon, Julie Bergeron, Hyeoung-Joon Kim, Heeje Kim, David Sanford, Andre C. Schuh, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4949.
https://doi.org/10.1182/blood-2023-190545
Published: 2023
Journal Articles

The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis

Ayman Sayyed, Hyewon Lee, Taehyung Simon Kim, Jaeyoon John Kim, Danielle Pyne, Nathali Kaushansky, Yardena Brilon, Noa Chapal-Ilani, Tamir Biezuner, Liran I. Shlush, Jan Storek, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 2207.
https://doi.org/10.1182/blood-2023-191191
Published: 2023
Journal Articles

Prognostic Analysis According to European Leukemianet 2022 Risk Stratification for Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine

Mihee Kim, Taehyung Simon Kim, Seo-Yeon Ahn, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Seunghyun Choi, MiYeon Kim, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 6094–6095.
https://doi.org/10.1182/blood-2022-164916
Published: 2022
Journal Articles

The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy

Maria Agustina Perusini, Taehyung Simon Kim, Daniela Žácková, Katia B Pagnano, Jiří Mayer, Carolina Pavlovsky, Ivana Ježíšková, Anežka Kvetková, Tomáš Jurček, Beatriz Moiraghi, Ana Ines Varela, Michele Bianchini, Ana Beatriz Pascoal Lopes, Gislaine B O Duarte, Young Seok Yoo, Carmino Antonio Souza, Jessie Medeiros, Hye Won Lee, Kyoung Ha Kim, Seong Yoon Yi, Myung Hee Chang, Sagi Abelson, Dennis Dong Hwan Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 6774–6775.
https://doi.org/10.1182/blood-2022-168228
Published: 2022
Journal Articles

In Vitro Evidence of Double Blockade of Asciminib with Reduced Dose of ATP-Binding Pocket Inhibitors in the Treatment of Chronic Myeloid Leukemia Harboring ABL1 Kinase Domain Mutation

Ho-Jae Han, Hyeok-Jae Jang, Youngseok Yoo, Taehyung Simon Kim, Jong-Won Kim, Dennis Dong Hwan Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 9588–9589.
https://doi.org/10.1182/blood-2022-165593
Published: 2022
Journal Articles

Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure

Maria Agustina Perusini, Katia B Pagnano, Carolina Pavlovsky, Beatriz Moiraghi, Ana Ines Varela, Michele Bianchini, Jiří Mayer, Daniela Žácková, Anežka Kvetková, Tomáš Jurček, Ivana Ježíšková, Ana Beatriz Pascoal Lopes, Gislaine B O Duarte, Carmino Antonio Souza, Jessie J.F. Medeiros, Taehyung Simon Kim, Young Seok Yoo, Kyoung Ha Kim, Hye Won Lee, Myung Hee Chang, Seong Yoon Yi, Sagi Abelson, Dennis Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 6782–6783.
https://doi.org/10.1182/blood-2022-167927
Published: 2022
Journal Articles

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

Taehyung Simon Kim, PhD, Zhaolei Zhang, PhD, Marc Tyndel, Jae-Sook Ahn, MDPhD, Yeo-Kyeoung Kim, MD, PhD, Seung Hyun Choi, PhD, Hyeoung-Joon Kim, MD PhD, Moses Lee, Murim Choi, Jeffrey H. Lipton, MD PhD, Dennis Dong Hwan Kim, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2596.
https://doi.org/10.1182/blood.V126.23.2596.2596
Published: 2015
Journal Articles

Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation

Taehyung Simon Kim, Zhaolei Zhang, PhD, Marc Tyndel, Jae-Sook Ahn, MDPhD, Seunghyun Choi, PhD, Hyeoung Joon Kim, Jeffrey H. Lipton, MD PhD, Dennis Dong Hwan Kim, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1568.
https://doi.org/10.1182/blood.V126.23.1568.1568
Published: 2015